• SENSEX 76,917.85
    1,225.07 (+1.62%)
  • BANKNIFTY 55,540.05
    537.85 (+0.98%)
  • NSE
    1,782.00 1,640.25(%)
  • Jio Platforms
    1,400.60 1,356.40(%)
  • Bharti Airtel
    1,996.35 1,726.05(%)
  • Reliance Industries
    1,281.55 1,152.30(%)
  • BLS Polymers
    225.00 225.00(%)
  • Solar Industries
    19,447.55 11,641.10(%)
  • Multi Comm. Exc.
    3,253.00 1,761.43(%)
  • Aegis Logistics
    1,084.75 576.00(%)
  • SBI
    961.35 933.85(%)
  • HDFC Bank
    705.80 668.90(%)
  • Oil India
    451.30 395.75(%)
  • Garden Reach Sh.
    2,050.55 1,840.00(%)
  • Divi's Lab.
    9,866.35 5,648.00(%)
  • M & M Fin. Serv.
    262.20 253.30(%)
  • Sagility
    41.98 35.82(%)
  • SFC Enviro.
    354.05 354.05(%)
  • Mankind Pharma
    2,461.50 1,909.90(%)
  • M & M
    2,863.00 2,743.15(%)
  • Kanohar Elect.
    1,017.00 672.05(%)
  • Laurus Labs
    2,252.50 913.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Kopran Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Parijat
  • BSE Code : 2717.0
  • ISIN : INE082A01010
246.16 4 (1.63%)
  • As on 04 Nov 2026 (EOD)

  • Today’s Low

    221.61

  • Today’s High

    254.99

  • Open

    244.70

  • Perv Close

    242.21

  • 52W Low

    107.00

  • 52W High

    295.83

Key Indicators

  • P/E(TTM)

    35.51

  • Mar.Cap (₹Cr.)

    1,189.60

  • Div & Yield %

    1.21

  • Book Value(₹)

    92.68

  • Debt-Equity Ratio

    1.63

  • AGM Date

    03-Nov-2026

  • EPS

    6.95

  • P/E Ratio

    35.51

Financials Ratios

  • Debt-Equity Ratio

    0.19

  • Mar.Cap (₹Cr.)

    1,189.60

  • RONW (%)

    10.95

  • ROCE (%)

    13.57

Score Board

  • Equity (₹ in Cr.)

    48.33

  • BV (₹)

    92.70

  • Sales( ₹ in Cr.)

    305.65

  • NP (in Cr.)

    30.40

  • NP Var(%)

    13.0

  • Div%

    30.0

  • CPS (₹)

    7.30

  • EPS (₹)

    6.30

  • Traded Value (₹ in Lakhs)

    1,192.69

  • 52 Week High

    295.83

  • 52 Week Low

    107.00

  • Price BSE

    247.0

  • Price NSE

    246.00

  • Market Capital( in Cr.)

    1,192.69

  • P/C Ratio

    33.70

  • P/E Ratio

    39.30

  • Price Vs.BV

    6.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 305.65 271.01 337.46 273.09 204.52 222.83
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 305.65 271.01 337.46 273.09 204.52 222.83
Other Income 2.00 5.90 16.71 16.09 8.03 10.41
Stock Adjustments -3.79 1.84 1.74 -3.55 3.93 -14.70
Total Income 303.86 278.75 355.91 285.63 216.48 218.54
EXPENDITURE :            
Raw Materials 166.35 159.22 231.89 174.14 131.75 123.04
Power and Fuel Cost 9.69 8.59 7.89 7.58 6.51 5.68
Employee Cost 32.94 30.02 25.61 25.15 21.05 18.34
Other Manufacturing Expenses 14.10 12.56 12.45 10.69 9.75 8.33
Selling and Administration Expenses 24.46 21.35 22.45 20.85 22.65 19.79
Miscellaneous Expenses 6.75 2.46 1.98 3.23 1.31 2.75
Employee Benefit Expenses 32.94 30.02 25.61 25.15 21.05 18.34
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 254.29 234.19 302.26 241.63 193.03 177.93
Operating Profit 49.58 44.56 53.64 44.00 23.44 40.62
Interest 4.20 3.77 4.50 2.67 2.95 3.81
Gross Profit 45.38 40.79 49.14 41.33 20.49 36.81
Depreciation 4.98 5.00 4.62 4.41 4.32 4.10
Profit Before Tax 40.40 35.79 44.52 36.92 16.17 32.71
Current Tax 9.04 8.63 10.08 5.87 3.75 5.76
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.96 0.31 -0.20 -0.21 0.67 3.48
Reported Net Profit 30.40 26.86 34.64 31.25 11.74 23.47
Extraordinary Items 0.00 0.00 -0.01 0.00 0.00 -0.01
Adjusted Net Profit 30.40 26.86 34.65 31.25 11.74 23.48
Adjustment below Net Profit 0.41 0.06 0.00 0.00 0.00 0.00
P & L Balance brought forward 111.83 99.38 79.20 62.41 57.15 40.17
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 14.49 14.46 14.46 14.46 6.49 6.49
P & L Balance carried down 128.15 111.83 99.38 79.20 62.41 57.15
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 30.00 30.00 30.00 30.00 30.00 30.00
Dividend Per Share(Rs) 3.00 3.00 3.00 3.00 3.00 3.00
Earnings Per Share-Unit Curr 6.30 5.56 7.18 6.48 2.44 5.43
Earnings Per Share(Adj)-Unit Curr 6.30 5.56 7.18 6.48 2.44 5.43
Book Value 92.75 89.35 86.47 82.05 78.56 57.07
Book Value(Adj)-Unit Curr 92.75 89.35 86.47 82.05 78.56 57.07

Shareholding Pattern

  • Promoter Group

    41.82%

  • Public Share Holding

    58.18%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 14,794,243 30.61 14,794,243 5
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3,653,210 7.56 3,653,210 3
Partnership Firms-Indian (Promoter & Group) 1,764,750 3.65 1,764,750 1
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 20,212,203 41.82 20,212,203 9
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 600 0.00 300 4
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 437,239 0.90 437,239 20
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 300 0.00 0 3
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 1,608 0.00 1,108 5
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 439,747 0.91 438,647 32
2] Non Institution
Bodies Corporate 2,810,181 5.82 2,790,581 300
Clearing Members 202,906 0.42 202,906 28
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,013,289 2.10 1,013,139 882
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,238,215 2.56 1,238,215 1,188
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 7,898,012 16.34 7,898,012 88
Individuals holding nominal share capital up to Rs. 1 lakh 14,494,238 29.99 14,258,715 50,389
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 1,948 0.00 1,948 2
Others 1,500 0.00 1,500 1
Sub Total 27,674,155 57.27 27,418,882 52,883
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 48,326,105 100.00 48,069,732 52,924

Company Background

Kopran LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Kopran Ltd
  • BSE Code : 2717.0
  • ISIN : INE082A01010

  • Incorporation Year

    1958

  • Registered Office

    Parijat House 1076
    Dr E Moses Road Worli, Mumbai,
    Maharashtra-400018

  • Telephone

    91-22-43661111

  • FAX

    91-22-24950363

  • Chairman

    Surendra Somani

  • Managing Director

    Surendra Somani

  • Company Secretary

    Sunil Sodhani

  • Auditor

    Khandelwal Jain & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Bigshare Services Pvt Ltd
    Office No S6-2,
    Pinnacle Busine.Park,Mahakali Caves Road
    Mumbai - Mumbai - 400093

Kopran Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Kopran 246.80 307.65 305.65 35.51 9.10
Abbott India 25,805.30 7,217.19 6,929.05 33.96 43.78
Astrazeneca Phar 6,340.60 2,304.07 2,275.58 93.45 27.86
Glaxosmi. Pharma 2,573.30 3,932.76 3,790.20 41.11 58.17
Novartis India 1,719.85 393.10 354.33 43.43 15.94
Cipla 1,392.20 20,102.60 18,979.95 42.43 13.88
Bliss GVS Pharma 637.90 773.53 729.81 41.58 12.51
Amrutanjan Healt 499.35 520.13 502.55 26.75 24.16
Fermenta Biotec. 427.55 474.15 450.25 19.96 18.77
Guj. Themis Bio. 377.25 168.25 165.82 100.87 18.05
Ambalal Sarabhai 34.90 19.52 3.94 64.63 6.77